SignatureFD’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-196
Closed -$48K 3451
2022
Q3
$48K Buy
196
+7
+4% +$1.89K ﹤0.01% 1291
2022
Q2
$47K Sell
189
-61
-24% -$16.5K ﹤0.01% 1332
2022
Q1
$83K Buy
250
+104
+71% +$32K ﹤0.01% 1128
2021
Q4
$52K Sell
146
-49
-25% -$16.6K ﹤0.01% 1327
2021
Q3
$63K Buy
195
+76
+64% +$25.7K ﹤0.01% 1194
2021
Q2
$37K Buy
119
+20
+20% +$6.13K ﹤0.01% 1426
2021
Q1
$32K Sell
99
-294
-75% -$94.1K ﹤0.01% 1380
2020
Q4
$127K Buy
+393
New +$109K 0.01% 684
2020
Q3
Sell
-101
Closed -$24K 2808
2020
Q2
$24K Buy
101
+23
+29% +$4.62K ﹤0.01% 1273
2020
Q1
$11K Buy
78
+68
+680% +$11.3K ﹤0.01% 1456
2019
Q4
$2K Sell
10
-2,360
-100% -$438K ﹤0.01% 1957
2019
Q3
$422K Sell
2,370
-26
-1% -$5.62K 0.03% 233
2019
Q2
$624K Sell
2,396
-63
-3% -$16.7K 0.05% 145
2019
Q1
$702K Sell
2,459
-16
-0.6% -$5.32K 0.06% 132
2018
Q4
$804K Buy
2,475
+52
+2% +$18.1K 0.07% 104
2018
Q3
$1.09M Sell
2,423
-2,747
-53% -$1.08M 0.11% 87
2018
Q2
$2.12M Buy
5,170
+4,410
+580% +$1.6M 0.24% 42
2018
Q1
$221K Sell
760
-4,355
-85% -$1.1M 0.03% 319
2017
Q4
$959K Hold
5,115
0.12% 72
2017
Q3
$862K Buy
5,115
+750
+17% +$113K 0.11% 67
2017
Q2
$626K Hold
4,365
0.09% 89
2017
Q1
$546K Sell
4,365
-26
-0.6% -$3.01K 0.08% 106
2016
Q4
$495K Sell
4,391
-2,100
-32% -$243K 0.08% 95
2016
Q3
$835K Buy
+6,491
New +$778K 0.12% 58
2014
Q1
Sell
-12,100
Closed -$324K 939
2013
Q4
$324K Sell
12,100
-10,000
-45% -$247K 0.12% 56
2013
Q3
$421K Hold
22,100
0.18% 44
2013
Q2
$476K Buy
+22,100
New +$444K 0.25% 45

Other funds holding ABMD

SignatureFD's ABMD Position: Q4 2022 in Review

SignatureFD sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 196 shares — an estimated $48K sold.

SignatureFD first reported a position in ABMD in Q2 2013 and held it in 27 quarters. The position peaked at $2.12M in Q2 2018. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • SignatureFD reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • SignatureFD sold 196 Abiomed Inc shares in Q4 2022, an estimated $48K.
  • SignatureFD first reported a position in Abiomed Inc in Q2 2013 and held it in 27 quarters.
  • SignatureFD's Abiomed Inc position peaked at $2.12M in Q2 2018.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on SignatureFD's 13F filing for Q4 2022, filed 30 Jan 2023.